BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35874943)

  • 1. Dysregulation of Innate and Adaptive Immune Responses in Asymptomatic SARS-CoV-2 Infection with Delayed Viral Clearance.
    Cao S; Zhang Q; Song L; Xiao M; Chen Y; Wang D; Li M; Hu J; Lin L; Zheng Y; Zhou K; Ye S; Zhou J; Zhou YN; Cui J; Wang J; Sun J; Tao J; Chen Z; Chen R; Zhou P; Shi Z; Wei S; Zhao L; Wang H; Tong X; Li X; Men D; Hou B; Zhang XE
    Int J Biol Sci; 2022; 18(12):4648-4657. PubMed ID: 35874943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses.
    Yang Y; Wang X; Du RH; Zhang W; Si HR; Zhu Y; Shen XR; Li Q; Li B; Men D; Zhou YN; Wang H; Tong XL; Zhang XE; Shi ZL; Zhou P
    Emerg Microbes Infect; 2021 Dec; 10(1):905-912. PubMed ID: 33870851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.
    Long QX; Tang XJ; Shi QL; Li Q; Deng HJ; Yuan J; Hu JL; Xu W; Zhang Y; Lv FJ; Su K; Zhang F; Gong J; Wu B; Liu XM; Li JJ; Qiu JF; Chen J; Huang AL
    Nat Med; 2020 Aug; 26(8):1200-1204. PubMed ID: 32555424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral dynamics and antibody responses in people with asymptomatic SARS-CoV-2 infection.
    Sui Z; Dai X; Lu Q; Zhang Y; Huang M; Li S; Peng T; Xie J; Zhang Y; Wu C; Xia J; Dong L; Yang J; Huang W; Liu S; Wang Z; Li K; Yang Q; Zhou X; Wu Y; Liu W; Fang X; Peng K
    Signal Transduct Target Ther; 2021 May; 6(1):181. PubMed ID: 33972497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 viral shedding and susceptibility: perspectives on gender and asymptomatic patients.
    Engku Abd Rahman ENS; Al-Fendi AMM; Irekeola AA; Musa N; Furusawa G; Chan YY
    J Infect Dev Ctries; 2022 May; 16(5):768-777. PubMed ID: 35656946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silent battles: immune responses in asymptomatic SARS-CoV-2 infection.
    Le Bert N; Samandari T
    Cell Mol Immunol; 2024 Feb; 21(2):159-170. PubMed ID: 38221577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID-19 patients.
    Chen Y; Li P; Ding Y; Liu M; Liu L; Yi B; Wu T; Dong H; Lao X; Ding K; Wang H; Zhang D; Tan X; Wang Z; Xu G; Cao G
    J Infect Public Health; 2021 Jul; 14(7):845-851. PubMed ID: 34118734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of COVID-19 Symptoms During SARS-CoV-2 Infection Defines Waning of Humoral Immunity.
    Wu J; Liang BY; Fang YH; Wang H; Yang XL; Shen S; Chen LK; Li SM; Lu SH; Xiang TD; Liu J; Le-Trilling VTK; Lu MJ; Yang DL; Deng F; Dittmer U; Trilling M; Zheng X
    Front Immunol; 2021; 12():722027. PubMed ID: 34489971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clinical and epidemiological characteristics of asymptomatic and symptomatic SARS-CoV-2 infection: A multi-center study in Sichuan Province, China.
    Kong W; Wang Y; Hu J; Chughtai A; Pu H;
    Travel Med Infect Dis; 2020; 37():101754. PubMed ID: 32492485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive Immunity to Viruses: What Did We Learn from SARS-CoV-2 Infection?
    Vályi-Nagy I; Uher F; Rákóczi É; Szekanecz Z
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interaction between SARS-CoV-2 and Host Innate Immunity].
    Duan XQ; Xie H; Chen LM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):1-6. PubMed ID: 35048592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Descriptive, Retrospective Study of the Clinical Characteristics of Asymptomatic COVID-19 Patients.
    Han H; Xu Z; Cheng X; Zhong Y; Yuan L; Wang F; Li Y; Liu F; Jiang Y; Zhu C; Xia Y
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33028689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
    White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
    Front Immunol; 2021; 12():801799. PubMed ID: 35222355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19.
    Almadhi MA; Abdulrahman A; Sharaf SA; AlSaad D; Stevenson NJ; Atkin SL; AlQahtani MM
    Int J Infect Dis; 2021 Apr; 105():656-661. PubMed ID: 33647516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate and Adaptive Immune Responses in the Upper Respiratory Tract and the Infectivity of SARS-CoV-2.
    Ramasamy R
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.
    Cunha LL; Perazzio SF; Azzi J; Cravedi P; Riella LV
    Front Immunol; 2020; 11():1748. PubMed ID: 32849623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mathematical modeling of interaction between innate and adaptive immune responses in COVID-19 and implications for viral pathogenesis.
    Du SQ; Yuan W
    J Med Virol; 2020 Sep; 92(9):1615-1628. PubMed ID: 32356908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2.
    Li W; Su YY; Zhi SS; Huang J; Zhuang CL; Bai WZ; Wan Y; Meng XR; Zhang L; Zhou YB; Luo YY; Ge SX; Chen YK; Ma Y
    Clin Microbiol Infect; 2020 Nov; 26(11):1556.e1-1556.e6. PubMed ID: 32653662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.
    Azkur AK; Akdis M; Azkur D; Sokolowska M; van de Veen W; Brüggen MC; O'Mahony L; Gao Y; Nadeau K; Akdis CA
    Allergy; 2020 Jul; 75(7):1564-1581. PubMed ID: 32396996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.